216 related articles for article (PubMed ID: 34266953)
1. Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP.
Chen Y; Hao Q; Wang S; Cao M; Huang Y; Weng X; Wang J; Zhang Z; He X; Lu H; Zhou X
Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34266953
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis.
Lou J; Hao Y; Lin K; Lyu Y; Chen M; Wang H; Zou D; Jiang X; Wang R; Jin D; Lam EW; Shao S; Liu Q; Yan J; Wang X; Chen P; Zhang B; Jin B
Mol Cancer; 2020 Sep; 19(1):138. PubMed ID: 32894144
[TBL] [Abstract][Full Text] [Related]
3. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer.
Deng X; Li S; Kong F; Ruan H; Xu X; Zhang X; Wu Z; Zhang L; Xu Y; Yuan H; Peng H; Yang D; Guan M
Theranostics; 2020; 10(1):265-280. PubMed ID: 31903119
[TBL] [Abstract][Full Text] [Related]
5. A potential synthetic lethal strategy with PARP inhibitors: perspective on 'Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP'.
Hao Q; Lu H; Zhou X
J Mol Cell Biol; 2021 Dec; 13(9):690-692. PubMed ID: 34375408
[No Abstract] [Full Text] [Related]
6. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
7. LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases.
Pan J; Zhang D; Zhang J; Qin P; Wang J
Cancer Biol Ther; 2019; 20(5):653-665. PubMed ID: 30582709
[TBL] [Abstract][Full Text] [Related]
8. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
9. LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB-mediated p53 ubiquitination.
Jiang X; Li H; Fang Y; Xu C
Environ Toxicol; 2022 Jun; 37(6):1495-1508. PubMed ID: 35213076
[TBL] [Abstract][Full Text] [Related]
10. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
11. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
12. Crucial role of TSC-22 in preventing the proteasomal degradation of p53 in cervical cancer.
Yoon CH; Rho SB; Kim ST; Kho S; Park J; Jang IS; Woo S; Kim SS; Lee JH; Lee SH
PLoS One; 2012; 7(8):e42006. PubMed ID: 22870275
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer.
Thorenoor N; Faltejskova-Vychytilova P; Hombach S; Mlcochova J; Kretz M; Svoboda M; Slaby O
Oncotarget; 2016 Jan; 7(1):622-37. PubMed ID: 26506418
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA RMRP promotes proliferation and invasion via targeting miR-1-3p in non-small-cell lung cancer.
Wang Y; Luo X; Liu Y; Han G; Sun D
J Cell Biochem; 2019 Sep; 120(9):15170-15181. PubMed ID: 31050363
[TBL] [Abstract][Full Text] [Related]
15. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling.
Zhang C; Liu J; Wang X; Wu R; Lin M; Laddha SV; Yang Q; Chan CS; Feng Z
Oncotarget; 2014 Oct; 5(19):9106-17. PubMed ID: 25193859
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression.
Guan X; Xu Y; Zheng J
Oncol Rep; 2020 Dec; 44(6):2465-2474. PubMed ID: 33125146
[TBL] [Abstract][Full Text] [Related]
18. The p53/RMRP/miR122 signaling loop promotes epithelial-mesenchymal transition during the development of silica-induced lung fibrosis by activating the notch pathway.
Huang R; Bai C; Liu X; Zhou Y; Hu S; Li D; Xiang J; Chen J; Zhou P
Chemosphere; 2021 Jan; 263():128133. PubMed ID: 33297121
[TBL] [Abstract][Full Text] [Related]
19. LncRNA NRON promotes tumorigenesis by enhancing MDM2 activity toward tumor suppressor substrates.
Guo Q; Li Y; Zhang Y; Shen L; Lin H; Chen J; Song E; Luo ML
EMBO J; 2023 Aug; 42(16):e112414. PubMed ID: 37382239
[TBL] [Abstract][Full Text] [Related]
20. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
